2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 3)

In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on continuous glucose monitoring during pregnancy and the postpartum period. Topics include pregnancy specific CGM targets, time in range and hypoglycemia thresholds, the role of CGM in type 1, type 2, and gestational diabetes, why glucose management indicator is not validated in pregnancy, evidence for maternal and neonatal outcomes, and CGM management during the postpartum and breastfeeding periods.